2011
DOI: 10.1371/journal.pone.0028479
|View full text |Cite
|
Sign up to set email alerts
|

Yeast Based Small Molecule Screen for Inhibitors of SARS-CoV

Abstract: Severe acute respiratory coronavirus (SARS-CoV) emerged in 2002, resulting in roughly 8000 cases worldwide and 10% mortality. The animal reservoirs for SARS-CoV precursors still exist and the likelihood of future outbreaks in the human population is high. The SARS-CoV papain-like protease (PLP) is an attractive target for pharmaceutical development because it is essential for virus replication and is conserved among human coronaviruses. A yeast-based assay was established for PLP activity that relies on the ab… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
39
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 39 publications
(40 citation statements)
references
References 21 publications
1
39
0
Order By: Relevance
“…1). Previous studies have shown that inactivation of the coronavirus papain-like protease by mutagenesis of the required catalytic cysteine residue or inhibition with a protease inhibitor blocks viral replication (23,34,35,41). These approaches demonstrate the requirement for protease activity but represent all-or-nothing approaches and do not allow for the study of reduced or impaired protease activity.…”
Section: Discussionmentioning
confidence: 99%
“…1). Previous studies have shown that inactivation of the coronavirus papain-like protease by mutagenesis of the required catalytic cysteine residue or inhibition with a protease inhibitor blocks viral replication (23,34,35,41). These approaches demonstrate the requirement for protease activity but represent all-or-nothing approaches and do not allow for the study of reduced or impaired protease activity.…”
Section: Discussionmentioning
confidence: 99%
“…In SARS-CoV, the main roles of PLpro enzymatic activity involve processing of the replicase polyprotein at the N terminus of pp1a, releasing the nonstructural proteins nsp1, nsp2, and nsp3 (27). Importantly, because of the essentiality of these events, inhibition of PLpro enzymatic activity is an ongoing approach for the development of anticoronaviral drugs (28)(29)(30)(31)(32)(33)(34)(35)(36)(37)(38). Other enzymatic activities involve the removal of the cellular substrates ubiquitin (Ub), termed deubiquitination (DUB), and interferon-stimulated gene 15 (ISG15), termed deISGylation, from host cell proteins (reviewed in reference 39).…”
mentioning
confidence: 99%
“…Furthermore, as S. cerevisiae is a simple single-cell organism with just about 6400 genes, advanced bioinformatics and system-biology tools are most powerful and accurate in yeast [111]. Importantly, S. cerevisiae have been used to study viral-induced apoptosis, viral mediated cell cycle regulation [10] and for drug screening [122].…”
Section: The Yeast Saccharomyces Cerevisiae: a Powerful System For Idmentioning
confidence: 99%